| Megan Rose Miller, ARNP | |
|
312 9th St Sw Ste 1200, Waverly, IA 50677-2909 | |
| (319) 352-4340 | |
| (319) 352-0745 |
| Full Name | Megan Rose Miller |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 312 9th St Sw Ste 1200, Waverly, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376063107 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A129791 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allen Hospital | Waterloo, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
The medical device company cerbomed cooperated with the Clinic for Psychiatry and Psychotherapy of the University of Regensburg 2010 on a randomized, controlled study into somatosensory pain processing. The study, lead by Prof. Dr. Peter Eichhammer and Dr. Volker Busch, aimed to judge the pain-relieving effect of transcutaneous Vagus Nerve Stimulation (t-VNS).
A mutation that enhances the function of a specific ion channel has been identified as the cause of a rare inherited pain disorder. The research, published by Cell Press in the June 10 issue of the journal Neuron, proposes a potential treatment for the disorder and may lead to a better understanding of chronic pain in humans.
› Verified 7 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
The medical device company cerbomed cooperated with the Clinic for Psychiatry and Psychotherapy of the University of Regensburg 2010 on a randomized, controlled study into somatosensory pain processing. The study, lead by Prof. Dr. Peter Eichhammer and Dr. Volker Busch, aimed to judge the pain-relieving effect of transcutaneous Vagus Nerve Stimulation (t-VNS).
A mutation that enhances the function of a specific ion channel has been identified as the cause of a rare inherited pain disorder. The research, published by Cell Press in the June 10 issue of the journal Neuron, proposes a potential treatment for the disorder and may lead to a better understanding of chronic pain in humans.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Rose Miller, ARNP 312 9th St Sw Ste 1200, Waverly, IA 50677-2909 Ph: (319) 352-4340 | Megan Rose Miller, ARNP 312 9th St Sw Ste 1200, Waverly, IA 50677-2909 Ph: (319) 352-4340 |
News Archive
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
The medical device company cerbomed cooperated with the Clinic for Psychiatry and Psychotherapy of the University of Regensburg 2010 on a randomized, controlled study into somatosensory pain processing. The study, lead by Prof. Dr. Peter Eichhammer and Dr. Volker Busch, aimed to judge the pain-relieving effect of transcutaneous Vagus Nerve Stimulation (t-VNS).
A mutation that enhances the function of a specific ion channel has been identified as the cause of a rare inherited pain disorder. The research, published by Cell Press in the June 10 issue of the journal Neuron, proposes a potential treatment for the disorder and may lead to a better understanding of chronic pain in humans.
› Verified 7 days ago
Teresa Anne Isaacson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-483-1390 Fax: 319-483-1399 | |
Mrs. Jodi Bangasser, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-483-1365 Fax: 319-352-3992 | |
Jan Paula Davis, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 312 9th St Sw Ste 3300, Waverly, IA 50677 Phone: 319-483-1400 Fax: 319-483-1439 | |
Carissa Jo Kelm, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 312 9th St. Sw, Waverly, IA 50677 Phone: 319-352-4120 | |
Rae Gene Hovenga, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 312 9th St Sw, Waverly, IA 50677 Phone: 319-352-4120 | |
Leeann Hoodjer, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Waverly Health Center, 312 9th Street Sw, Waverly, IA 50677 Phone: 319-352-4120 | |
Kerri Marie Vanee, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 99 E Bremer Ave Ste 100, Waverly, IA 50677 Phone: 319-239-9194 |